Press release
Non-alcoholic Steatohepatitis (NASH) Biomarkers Market CAGR Projected to Grow at 31.7% through 2024
Global NASH Biomarkers Market: SnapshotNon-alcoholic Steatohepatitis (NASH) is a degenerative form of non-alcoholic fatty liver disease (NAFLD) that leads to damage and inflammation over time. The unwanted fat deposition in liver is the main cause of this disease. If left untreated or undiagnosed, it can lead to liver cirrhosis and eventually progress to liver failure. The high prevalence of liver-related diseases has coaxed several industry players and research institutes to invest in development of sophisticated NASH diagnostic and therapeutic products. Owing to these reasons, the global NASH biomarkers is expected to reach a valuation of US$1.7 bn by the end of 2024 from US$201.2 mn in 2016. During the forecast period of 2016 and 2024, the global market is estimated to progress at a CAGR of 31.7%.
Increasing Number of Type 2 Diabetics to Augment Demand for NASH Biomarkers
Currently, histopathology using a liver biopsy which is an invasive method, imaging techniques like magnetic resonance imaging (MRI), transient Elastography (TE), ultrasound, etc., and in vitro diagnostic techniques using some biomarkers are used for diagnosing and monitoring NASH. However, the introduction of biomarkers has given the patients the option of non-invasive methods for understanding the stage and development of the disease. This precise factor is estimated to boost the market’s growth in the coming years.
Obtain Report Details @ https://www.transparencymarketresearch.com/non-alcoholic-steatohepatitis-biomarkers-market.html
Analysts anticipate that the global market will also be driven by the huge untapped need for diagnosing NASH. Furthermore, the growing number of type 2 diabetics are also expected to augment the demand for NASH biomarkers as they are prone to liver-related diseases. Changing lifestyles and improving healthcare expenditure is also likely to make a significant difference to the soaring revenue of the overall market.
Serum Biomarkers to Lead the Pack during Forecast Period
On the basis of type, the global NASH biomarkers market is segmented into serum biomarkers, hepatic fibrosis biomarkers, apoptosis biomarkers, and oxidative stress biomarkers. Of these, serum biomarkers and hepatic biomarkers are extensively used in the medical field. The serum biomarkers are expected to lead the global market due to ability to deliver efficient results.
Apoptosis markers follow this lead closely. In terms of end users, the global NASH biomarkers market is segmented into CRO and pharmaceutical industries, academic research institutes, hospitals, and diagnostic laboratories. The report suggests that hospitals and diagnostic laboratories are likely to dominate the global market in the coming years. The increasing demand for non-invasive NASH diagnostic and monitoring tools in the ongoing trials by CRO and pharmaceutical manufacturers are expected to boost the share of the respective segment over the forecast period as well.
Request for Sample Copy of Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=18650
Increasing Number of Patients with NAFLD and NASH keep Europe in Lead
In terms of geography, the global NASH biomarkers market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. Presently, Europe leads the pack due to the strong presence of players in the region. The report states that Europe will continue to dominate the global market due to the increasing pool of population suffering from NAFLD and NASH. Over the same period, North America will also show steady demand for NASH biomarkers due to its well-established healthcare industry and a huge population base.
The key players operating in the global NASH biomarkers market are Genfit SA, One Way Liver S.L., BioPredictive S.A.S, Siemens Heathcare Pvt. Ltd. (now Siemens Healthineers), Exalenz Biosciences Ltd., Prometheus Laboratories Corp. (part of Nestle Health Sciences), Quest Diagnostic Incorporated, and SNIBE diagnostics.
Enquiry for Discount on this Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=18650
About Us
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Contact Us
Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Non-alcoholic Steatohepatitis (NASH) Biomarkers Market CAGR Projected to Grow at 31.7% through 2024 here
News-ID: 1136616 • Views: …
More Releases from Transparency Market Research
Handheld Marijuana Vaporizer Market Key Drivers, Market Research, and Insights f …
The global handheld marijuana vaporizer market has witnessed remarkable growth in recent years, attributed to the increasing acceptance of medicinal marijuana and the demand for convenient and discreet consumption methods. Valued at US$ 5 billion in 2021, the market is projected to surge at a CAGR of 13.4% to reach US$ 15.9 billion by 2031. This article delves into the factors driving this growth, the evolving market landscape, and the…
Disinfectant Wipes Market Forecast 2020-2030 - Market Size, Drivers, Trends, And …
The COVID-19 pandemic has precipitated a remarkable surge in the demand for disinfectant products, with a notable emphasis on disinfectant wipes as an essential tool in maintaining hygiene and preventing the spread of pathogens. This research report delves into the multifaceted landscape of the disinfectant wipes market, elucidating key trends, drivers, and innovations shaping the industry.
𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐭𝐡𝐢𝐬 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐫𝐞𝐩𝐨𝐫𝐭 @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=70359
Key Players and Market Developments
Key players…
Tissue Banking Market is Expected to Reach US$ 2,903.3 Million to 2026| TMR Stud …
The global 𝐭𝐢𝐬𝐬𝐮𝐞 𝐛𝐚𝐧𝐤𝐢𝐧𝐠 𝐦𝐚𝐫𝐤𝐞𝐭 reached a value of US$ 1,056.4 million in 2017 and is projected to nearly triple to US$ 2,903.3 million by 2026, with a robust Compound Annual Growth Rate (CAGR) of approximately 12.0% from 2018 to 2026. Factors such as increasing awareness about tissue donation, technological advancements, and a growing target patient population are anticipated to propel market growth during this period.
Moreover, the market is expected…
Vascular Closure Devices Market to reach US$ 1 Billion by 2027: TMR Study
This report by Transparency Market Research, Inc. assesses the present state and future growth potential of the global 𝐯𝐚𝐬𝐜𝐮𝐥𝐚𝐫 𝐜𝐥𝐨𝐬𝐮𝐫𝐞 𝐝𝐞𝐯𝐢𝐜𝐞𝐬 𝐦𝐚𝐫𝐤𝐞𝐭. It features a comprehensive executive summary, offering insights into various segments of the market. Additionally, the report provides detailed analysis and data on product, access type, application, end user, and regional segments within the global market.
Vascular closure devices is estimated to reach a value of ~US$ 1 Bn…
More Releases for NASH
NASH Market Insight and Landscape report
Report Snapshot:
NASH is one of the furthermost causes of liver disease worldwide and will probably emerge as the leading cause of end-stage liver disease in the coming years, with the disease affecting both adults and children. The epidemiology and demographic characteristics of NASH vary across different country level. Furthermore, individuals with NAFLD have a high frequency of metabolic comorbidities and could place a growing strain on health-care systems from their…
IQ4I Research published “Non-alcoholic steatohepataitis (NASH) Pipeline Analys …
“Non-alcoholic steatohepataitis (NASH) Pipeline Analysis” gives comprehensive insights on the various drugs being developed for the treatment of NASH. The report covers all the drugs that are in various phases of development (Discovery, Preclinical & Clinical). The pipeline focuses on novel pharmacologic drugs & regenerative medicines covering small molecules, antibodies, stem cell therapies, recombinant proteins and RNA-based therapeutics, but excludes symptom relief drugs, generic combinations and supplemental drugs. The report…
Growing Prevalence of NASH to Increase Adoption of Therapeutics
"The Report OpportunityAnalyzer: NASH - Opportunity Analysis and Forecasts to 2026 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"
MarketResearchReports.biz has itemized the addition of a new market research report to its report repository. The research publication is titled, “Opportunity Analyzer: NASH - Opportunity Analysis and Forecasts to 2026.” The statistical surveying study is a watchful inspection of the general market…
OpportunityAnalyzer: NASH - Opportunity Analysis and Forecasts to 2026
First described in 1980, nonalcoholic steatohepatitis (NASH) (ICD-10-CM = K75.81) is a condition that develops as a subgroup of nonalcoholic fatty liver disease (NAFLD) when excessive fat buildup is accompanied by liver cell injury and inflammation. NAFLD is defined by excessive fat accumulation in the form of triglycerides (steatosis) in the liver. Progression of this condition to NASH dramatically increases the risk of cirrhosis, liver failure, and hepatocellular carcinoma, and…
Nash releases debut EP 'She Don't Know'
London-based singer/songwriter Nash has released his debut EP She Don’t Know. Recorded at the legendary RAK Studios, She Don’t Know has the feel of 60s rock but with a modern twist, leaving the listener hooked throughout and wanting to come back for another listen. She Don’t Know’s leading single CK is an infectious number which is sure to be a hit for 2017.
Listening to the Beatles and Jack White growing…
Nash Technologies at GITEX/GULFCOMMS 2010
Harvey Nash subsidiary presents expert services to telecom operators in the Middle East, Africa and South Asia region
Nürnberg/Germany, 10th September 2010 – For the first time Nash Technologies will be present at GITEX/GULFCOMMS, the largest international trade event for mobile, fixed, IP and satellite communications for the Middle East, Africa and South Asia region, in Dubai from 17th to 21st October 2010 offering its telecom expert services. Nash Technologies will…
